Lisuride and other dopamine agonists: basic mechanisms and endocrine and neurolog. effects
Gespeichert in:
| Format: | Tagungsbericht Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York
Raven Pr.
1983
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XXI, 553 S. Ill. |
| ISBN: | 0890048673 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV000317775 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 870612s1983 a||| |||| 10||| eng d | ||
| 020 | |a 0890048673 |9 0-89004-867-3 | ||
| 035 | |a (OCoLC)230811203 | ||
| 035 | |a (DE-599)BVBBV000317775 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-188 |a DE-578 | ||
| 084 | |a YH 2500 |0 (DE-625)153529:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Lisuride and other dopamine agonists |b basic mechanisms and endocrine and neurolog. effects |c ed.: Donald B. Calne ... |
| 264 | 1 | |a New York |b Raven Pr. |c 1983 | |
| 300 | |a XXI, 553 S. |b Ill. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 0 | 7 | |a Lisurid |0 (DE-588)4167835-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Dopamin |0 (DE-588)4012737-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Dopa |0 (DE-588)4150420-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Agonist |0 (DE-588)4380725-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1981 |z Berlin West |2 gnd-content | |
| 689 | 0 | 0 | |a Dopamin |0 (DE-588)4012737-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Lisurid |0 (DE-588)4167835-7 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Dopa |0 (DE-588)4150420-3 |D s |
| 689 | 2 | 1 | |a Agonist |0 (DE-588)4380725-2 |D s |
| 689 | 2 | |5 DE-604 | |
| 700 | 1 | |a Calne, Donald B. |d 1936- |e Sonstige |0 (DE-588)128984481 |4 oth | |
| 711 | 2 | |a International Workshop on Lisuride and Other Dopamine Agonists |n 1 |d 1981 |c Berlin, West |j Sonstige |0 (DE-588)809101-8 |4 oth | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000195175&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-000195175 | ||
Datensatz im Suchindex
| _version_ | 1804114782767284224 |
|---|---|
| adam_text | LISURIDE AND OTHER DOPAMINE AGONISTS BASIC MECHANISMS AND ENDOCRINE AND
NEUROLOGICAL EJFECTS EDITORS DONALD B. CALNE, D.M., F.R.C.P. DIVISION OF
NEUROLOGY DEPARTMENT OF MEDICINE UNIVERSITY OF BRITISH COLUMBIA
VANCOUVER, BRITISH COLUMBIA, CANADA REINHARD HOROWSKI, DR. MED.
DEPARTMENT OF NEUROENDOCRINOLOGY AND NEUROPSYCHOPHARMACOLOGY SCHERING AG
BERLIN, FEDERAL REPUBLIC OF GERMANY RICHARD J. MCDONALD, PH.D.
DEPARTMENT OF NEUROENDOCRINOLOGY AND NEUROPSYCHOPHARMACOLOGY SCHERING AG
BERLIN, FEDERAL REPUBLIC OF GERMANY WOLFGANG WUTTKE, PROF. DR. MED.
DEPARTMENT OF NEUROBIOLOGY MAX-PLANCK-INSTITUTE FOR BIOPHYSICAL
CHEMISTRY GOTTINGEN FEDERAL REPUBLIC OF GERMANY RAVEN I N CONTENTS
INTRODUCTION 1 DOPAMINERGIC ERGOT COMPOUNDS: AN OVERVIEW E. FLIICKIGER,
U. BRINER, A. ENZ, R. MARKSTEIN, ANDJ. M. VIGOURET RECEPTOR PHARMACOLOGY
F 11 HETEROGENEITY OF BRAIN DOPAMINE SYSTEMS: POSSIBLE DISCRIMINATION
OF DIFFERENT TYPES OF DOPAMINE SYSTEMS AND RECEPTORS BY ERGOT DRUGS K.
FUXE, L. F. AGNATI, C. KOHLER, K. ANDERSSON, P. ENEROTH, L. CALZA, AND
S.-O. OGREN ^ 33 ERGOT-INDUCED INHIBITION OF DOPAMINE SYNTHESIS IN
STRIATAL SYNAPTOSOMES: A D-2 DA RECEPTOR-MEDIATED MECHANISM A. H.
TISSARI AND G. L. GESSA X 45 ACTIONS OF LISURIDE ON ADRENOCEPTORS AND
DOPAMINE RECEPTORS T. E. COTE, R. L. ESKAY, E. A. FREY, C. W. GREWE, M.
MUNEMURA, K. TSURUTA, E. M. BROWN, AND J . W. KEBABIAN 55 ESTROGEN
MODULATION OF DOPAMINOMIMETIC ACTIONS: IMPLICATIONS FOR AUTORECEPTOR
REGULATION M. P. PICCARDI, F. BERNARDI, A. BOCCHETTA, AND G. U. CORSINI
BEHAVIORAL PHARMACOLOGY 65 BEHAVIORAL PHARMACOLOGY OF ERGOT DERIVATIVES
MICHELE O. CARRUBA AND PAOLO MANTEGAZZA 79 LISURIDE-INDUCED MOUNTING
BEHAVIOR AND EFFECTS ON THE MONOAMINERGIC SYSTEM IN RAT BRAIN H. H.
KELLER, E. P. BONETTI, L. PIERI, AND M. DA PRADA 89 BEHAVIORAL,
NEUROCHEMICAL, AND ELECTROPHYSIOLOGICAL EFFECTS OF LISURIDE AND LSD IN
ANIMALS L. PIERI, H. H. KELLER, J.-P. LAURENT, W. P. BURKARD, M. PIERI,
E. P. BONETTI, AND M. DA PRADA VU VIII CONTENTS 97 EFFECT OF CHRONIC
LISURIDE TREATMENT ON STEREOTYPICAL AND MYOCLONIC JUMPING BEHAVIOR IN
GUINEA PIGS PAUL M. CARVEY AND HAROLD L. KLAWANS F 109 CENTRAL
DOPAMINERGIC AND ANTIDOPAMINERGIC EFFECTS OF ERGOT DERIVATIVES
STRUCTURALLY RELATED TO LISURIDE HELMUT WACHTEL 127 PHARMACOLOGICAL
EFFECTS OF LISURIDE AND THEIR POTENTIAL ROLE IN FURTHER RESEARCH R.
HOROWSKI PHARMACOKINETICS 141 PHARMACOKINETICS OF LISURIDE IN ANIMAL
SPECIES AND HUMANS MICHAEL HIIMPEL 153 DISPOSITION OF DOPAMINERGIC ERGOT
COMPOUNDS FOLLOWING ORAL ADMINISTRATION R. STANLEY BURNS AND DONALD B.
CALNE 161 NEUROENDOCRINE EFFECTS OF LISURIDE AND ITS 9,10-DIHYDROGENATED
ANALOG IN HEALTHY VOLUNTEERS R. DOROW, M. BREITKOPF, K.-J. GRAF, AND R.
HOROWSKI ENDOCRINOLOGIC PHARMACOLOGY F I 175 NEUROENDOCRINE EFFECTS OF
DOPAMINE IN THE HYPOTHALAMUS AND I PITUITARY GLAND W. WUTTKE, E.
DUKER, K. HONMA, M. DEMAJO, S. A. DE LIRA, M. LOHSE, AND T. MANSKY 187
EFFECT OF LISURIDE ON SPONTANEOUS PITUITARY TUMORS IN FEMALE RATS M. F.
EL ETREBY, D. DEHNE, S. H. HASAN, R. HOROWSKI, K. KOVACS, AND D. MCCOMB
{TYLJ 199 EFFECTS OF DOPAMINE AGONISTS ON PROLACTIN, GROWTH HORMONE,
AND ^ CORTISOL SECRETION IN ANIMALS AND HUMANS K.-J. GRAF AND I. KTIRTEN
213 DOPAMINE AGONISTS AND PROLACTINOMAS: CLINICAL AND BASIC CONSID-
ERATIONS OF THE MECHANISMS OF ACTION MICHAEL O. THORNER, JOSE A.
BURDMAN, MARIA T. CALABRESE, CARLOS A. VALDENEGRO, MARY L. VANCE, AND
ROBERT M. MACLEOD CONTENTS IX 231 MEDICAL TREATMENT OF PITUITARY
ADENOMAS: EFFECTS ON HORMONAL SECRETION AND TUMOR SIZE A. LIUZZI, P. G.
CHIODINI, G. OPPIZZI, D. DALLABONZANA, B. SPELTA, F. SILVESTRINI, E.
RAINER, AND R. HOROWSKI HORMONAL AND CLINICAL EFFECTS OF DOPAMINE
AGONISTS G. M. BESSER, J. A. H. WASS, A. GROSSMAN, P. J. A. MOULT, AND
P. BOULOUX 255 DOPAMINE AGONISTS AND PROLACTINOMAS: CLINICAL AND
THERAPEUTIC ASPECTS KLAUS VON WERDER, RUDOLF FAHLBUSCH, AND
HANNS-KRISTIAN RJOSK 271 COMPARISON OF EFFECTS OF DOPAMINE AGONISTS AND
MICROSURGERY IN GH- AND PRL-SECRETING ADENOMAS D. K. LUDECKE, H.-D.
HERRMANN, C. HORMANN, U. DESAGA, AND W. SAEGER 291 DOPAMINERGIC ERGOTS
IN LACTATION AND CYCLE DISTURBANCES LUIGI DE CECCO, PIER LUIGI
VENTURINI, NICOLA RAGNI, MARIO VALENZANO, SERGIO COSTANTINI, AND
REINHARD HOROWSKI 301 SUPPRESSION OF LACTATION M. SCHMIDT-GOLLWITZER 313
PROLACTIN AND THE INADEQUATE CORPUS LUTEUM H. P. G. SCHNEIDER, R.
GOESER, AND U. CIRKEL 325 EFFECT OF BROMOCRIPTINE ON LH SECRETION IN THE
POLYCYSTIC OVARY SYNDROME PAOLO FALASCHI AND EMILIO DEL POZO 111
LISURIDE AND FEMALE FERTILITY W. H. F. SCHNEIDER 337 EFFECTS OF
PROLACTIN-LOWERING AGENTS IN THE TREATMENT OF DISORDERS OF FERTILITY M.
CARSTENSEN, R. SOHNCHEN, W. BRAENDLE, AND G. BETTENDORF 345 EEG AND
PSYCHOLOGICAL EFFECTS OF LISURIDE IN WOMEN WITH PREMENSTRUAL TENSION M.
SCHWIBBE, D. BECKER, AND W. WUTTKE NEUROLOGICAL PHARMACOLOGY 357 ERGOT
DERIVATIVES AND EXTRAPYRAMIDAL DISEASE DONALD B. CALNE X CONTENTS 363
THEORETICAL AND PRACTICAL ISSUES IN ASSESSMENT OF DEFICITS AND THERAPY
IN PARKINSONISM T. ANDREO LARSEN, PETER A. LEWITT, AND DONALD B. CALNE
375 DESENSITIZATION OF STRIATAL SPIPERONE-BINDING SITES BY DOPAMIN-
ERGIC AGONISTS IN PARKINSON S DISEASE P. RIEDERER, G. P. REYNOLDS, W.
DANIELCZYK, K. JELLINGER, AND D. SEEMANN 383 INTRAVENOUS LISURIDE IN
EXTRAPYRAMIDAL DISORDERS N. QUINN, C. D. MARSDEN, M. SCHACHTER, C.
THOMPSON, A. E. LANG, AND J. D. PARKES 395 TREATMENT OF THE SHY-DRAGER
SYNDROME WITH DOPAMINERGIC ERGOTS A. J. LEES AND ROGER BANNISTER 407
DOPAMINERGIC ERGOTS IN PARKINSONISM ALESSANDRO AGNOLI, STEFANO RUGGIERI,
MASSIMO BALDASSARRE, FABRIZIO STOCCHI, ALESSANDRO DENARO, AND PAOLO
FALASCHI 419 LISURIDE IN PARKINSON S DISEASE AND RELATED DISORDERS
ABRAHAM N. LIEBERMAN, MENEK GOLDSTEIN, GOVINDAN GOPINATHAN, ANDREAS
NEOPHYTIDES, MORTON LEIBOWITZ, RUSSELL WALKER, AND EMIL HIESIGER 431 NEW
ERGOT DERIVATIVES IN THE TREATMENT OF PARKINSON S DISEASE U. K. RINNE
443 PERGOLIDE TREATMENT IN PARKINSONISM JOYCE ILSON, STANLEY FAHN,
RICHARD MAYEUX, AND LUCIEN COTE 453 EFFECTS OF LISURIDE ON MOTOR
FUNCTION, PSYCHOMOTOR ACTIVITY, AND PSYCHIC BEHAVIOR IN PARKINSON S
DISEASE W. BIRKMAYER AND P. RIEDERER 463 EXPERIENCE WITH LISURIDE IN THE
TREATMENT OF PARKINSON S DISEASE GUDRUN ULM 473 EXPERIENCE WITH DOPAMINE
AGONISTS IN PARKINSON S DISEASE AND RELATED DISORDERS PETER A. LEWITT
AND DONALD B. CALNE 481 DOPAMINE AS AN AGONIST IN OPIATE AND ENDOGENOUS
OPIOID (MIGRAINE) ABSTINENCE FEDERIGO SICUTERI AND MARCELLO FANCIULLACCI
CONTENTS ** PHARMACOLOGY OF AGING 489 REGULATION OF MONOAMINE METABOLISM
IN YOUNG AND OLD RATS: EFFECTS OF ERGOT DERIVATIVES WOLFGANG KEHR 503
ROLE OF LISURIDE AND OTHER DOPAMINE AGONISTS IN MEMORY RETRIEVAL
PROCESSES DAVID QUARTERMAIN, MARTIN E. JUDGE, AND EITAN FRIEDMAN 515
EFFECTS OF LISURIDE ON PSYCHOMOTOR FUNCTIONS AND RECALL MEMORY IN
ELDERLY HEALTHY VOLUNTEERS RICHARD J. MCDONALD AND ALOYSIUS ROHLOFF 529
CLINICAL EFFECTS OF DOPAMINE AGONISTS IN ELDERLY PATIENTS IRMGARD H.
SUCHY 543 SUBJECT INDEX
|
| any_adam_object | 1 |
| author_GND | (DE-588)128984481 |
| building | Verbundindex |
| bvnumber | BV000317775 |
| classification_rvk | YH 2500 |
| ctrlnum | (OCoLC)230811203 (DE-599)BVBBV000317775 |
| discipline | Medizin |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01795nam a2200433 c 4500</leader><controlfield tag="001">BV000317775</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">870612s1983 a||| |||| 10||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0890048673</subfield><subfield code="9">0-89004-867-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)230811203</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV000317775</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-188</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YH 2500</subfield><subfield code="0">(DE-625)153529:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Lisuride and other dopamine agonists</subfield><subfield code="b">basic mechanisms and endocrine and neurolog. effects</subfield><subfield code="c">ed.: Donald B. Calne ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Raven Pr.</subfield><subfield code="c">1983</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXI, 553 S.</subfield><subfield code="b">Ill.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lisurid</subfield><subfield code="0">(DE-588)4167835-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Dopamin</subfield><subfield code="0">(DE-588)4012737-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Dopa</subfield><subfield code="0">(DE-588)4150420-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Agonist</subfield><subfield code="0">(DE-588)4380725-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1981</subfield><subfield code="z">Berlin West</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Dopamin</subfield><subfield code="0">(DE-588)4012737-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Lisurid</subfield><subfield code="0">(DE-588)4167835-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Dopa</subfield><subfield code="0">(DE-588)4150420-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Agonist</subfield><subfield code="0">(DE-588)4380725-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Calne, Donald B.</subfield><subfield code="d">1936-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)128984481</subfield><subfield code="4">oth</subfield></datafield><datafield tag="711" ind1="2" ind2=" "><subfield code="a">International Workshop on Lisuride and Other Dopamine Agonists</subfield><subfield code="n">1</subfield><subfield code="d">1981</subfield><subfield code="c">Berlin, West</subfield><subfield code="j">Sonstige</subfield><subfield code="0">(DE-588)809101-8</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000195175&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000195175</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1981 Berlin West gnd-content |
| genre_facet | Konferenzschrift 1981 Berlin West |
| id | DE-604.BV000317775 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T15:12:12Z |
| institution | BVB |
| institution_GND | (DE-588)809101-8 |
| isbn | 0890048673 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000195175 |
| oclc_num | 230811203 |
| open_access_boolean | |
| owner | DE-12 DE-188 DE-578 |
| owner_facet | DE-12 DE-188 DE-578 |
| physical | XXI, 553 S. Ill. |
| publishDate | 1983 |
| publishDateSearch | 1983 |
| publishDateSort | 1983 |
| publisher | Raven Pr. |
| record_format | marc |
| spelling | Lisuride and other dopamine agonists basic mechanisms and endocrine and neurolog. effects ed.: Donald B. Calne ... New York Raven Pr. 1983 XXI, 553 S. Ill. txt rdacontent n rdamedia nc rdacarrier Lisurid (DE-588)4167835-7 gnd rswk-swf Dopamin (DE-588)4012737-0 gnd rswk-swf Dopa (DE-588)4150420-3 gnd rswk-swf Agonist (DE-588)4380725-2 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1981 Berlin West gnd-content Dopamin (DE-588)4012737-0 s DE-604 Lisurid (DE-588)4167835-7 s Dopa (DE-588)4150420-3 s Agonist (DE-588)4380725-2 s Calne, Donald B. 1936- Sonstige (DE-588)128984481 oth International Workshop on Lisuride and Other Dopamine Agonists 1 1981 Berlin, West Sonstige (DE-588)809101-8 oth GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000195175&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Lisuride and other dopamine agonists basic mechanisms and endocrine and neurolog. effects Lisurid (DE-588)4167835-7 gnd Dopamin (DE-588)4012737-0 gnd Dopa (DE-588)4150420-3 gnd Agonist (DE-588)4380725-2 gnd |
| subject_GND | (DE-588)4167835-7 (DE-588)4012737-0 (DE-588)4150420-3 (DE-588)4380725-2 (DE-588)1071861417 |
| title | Lisuride and other dopamine agonists basic mechanisms and endocrine and neurolog. effects |
| title_auth | Lisuride and other dopamine agonists basic mechanisms and endocrine and neurolog. effects |
| title_exact_search | Lisuride and other dopamine agonists basic mechanisms and endocrine and neurolog. effects |
| title_full | Lisuride and other dopamine agonists basic mechanisms and endocrine and neurolog. effects ed.: Donald B. Calne ... |
| title_fullStr | Lisuride and other dopamine agonists basic mechanisms and endocrine and neurolog. effects ed.: Donald B. Calne ... |
| title_full_unstemmed | Lisuride and other dopamine agonists basic mechanisms and endocrine and neurolog. effects ed.: Donald B. Calne ... |
| title_short | Lisuride and other dopamine agonists |
| title_sort | lisuride and other dopamine agonists basic mechanisms and endocrine and neurolog effects |
| title_sub | basic mechanisms and endocrine and neurolog. effects |
| topic | Lisurid (DE-588)4167835-7 gnd Dopamin (DE-588)4012737-0 gnd Dopa (DE-588)4150420-3 gnd Agonist (DE-588)4380725-2 gnd |
| topic_facet | Lisurid Dopamin Dopa Agonist Konferenzschrift 1981 Berlin West |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000195175&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT calnedonaldb lisurideandotherdopamineagonistsbasicmechanismsandendocrineandneurologeffects AT internationalworkshoponlisurideandotherdopamineagonistsberlinwest lisurideandotherdopamineagonistsbasicmechanismsandendocrineandneurologeffects |